Q2 2022 Coloplast A/S Earnings Call Transcript
Hello, and welcome to the Coloplast Interim Financial Statements for Q2 2022. (Operator Instructions) And today, I'm pleased to present Kristian Villumsen, President and CEO. Please begin your meeting.
/-&
Thank you, operator. Good afternoon, and welcome to our half year '21/'22 conference call. My name is Kristian Villumsen, CEO of Coloplast. I'm joined by our CFO, Anders Lonning-Skovgaard, and our Investor Relations team. We will start with a short presentation by Anders and myself and then open up for all of the questions that you may have.
Please turn to Slide #3. In Q2, we delivered 7% organic growth and an EBIT margin before special items of 31%. We delivered a respectable return on invested capital of 25% after tax and before special items, which is naturally impacted by the recent acquisition of Atos Medical. Reported growth in Danish kroner was 16% and Atos Medical contributed 6 percentage points to the reported growth and delivered high single
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
